...
首页> 外文期刊>Cornea >Collagen cross-linking (CCL) with sequential topography-guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty.
【24h】

Collagen cross-linking (CCL) with sequential topography-guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty.

机译:胶原蛋白交联(CCL)与顺序地形学指导的PRK:圆锥形角膜的替代性穿透性角膜移植术。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To assess the effectiveness of ultraviolet A (UVA) irradiation-induced collagen cross-linking (CCL) on keratoconus (KC) progression. METHODS: A patient with bilateral, progressive KC underwent UVA irradiation (3 mW/cm for 30 minutes) after topical 0.1% riboflavin drops over a deepithelialized cornea. Twelve months later, a topography-guided penetrating keratoplasty (PRK; wavelight 400 Hz Eye-Q excimer) was performed in 1 eye for a refractive error of -3.50 -4.00 x 155 by using an attempted treatment of -2.50 -3.00 x 155. At all postoperative follow-up visits to 18 months, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), pachymetry, and topography were performed. RESULTS: In the treated left eye, the UCVA after the UVA CCL improved from 20/100 to 20/80, and the BSCVA improved from 20/50 to 20/40. Eighteen months after the topography-guided PRK, the UCVA was 20/20, and the BSCVA was 20/15, with a refractive error of Plano -0.50 x 150. The cornea was clear, and the endothelial cell count remained unchanged. The untreated right mate eye continued to progress during the same period. CONCLUSIONS: The significant clinical improvement and the apparent stability of more than a year after UVA CCL, and subsequent PRK compared with the untreated mate eye, seems to validate this treatment approach for KC. An adjusted nomogram may be considered in the ablation of cross-linked cornea tissue to avoid overcorrections.
机译:目的:评估紫外线A(UVA)辐射诱导的胶原交联(CCL)对圆锥角膜(KC)进展的有效性。方法:双侧进行性KC患者在局部上皮化角膜上局部滴加0.1%核黄素后,接受UVA照射(3 mW / cm持续30分钟)。 12个月后,通过尝试对-2.50 -3.00 x 155进行治疗,在1只眼中进行了地形引导的穿透性角膜移植手术(PRK; 400Hz Eye-Q Wavelight准分子准分子),屈光度为-3.50 -4.00 x 155。在术后18个月的所有随访中,均进行了未矫正视力(UCVA),最佳眼镜矫正视力(BSCVA),测厚法和地形图。结果:在接受治疗的左眼中,UVA CCL后的UCVA从20/100改善到20/80,BSCVA从20/50改善到20/40。地形指导的PRK术后18个月,UCVA为20/20,BSCVA为20/15,屈光度为-0.50 x150。角膜透明,内皮细胞计数保持不变。在同一时期,未经治疗的右伴侣眼睛继续发展。结论:与未经治疗的伴侣眼相比,UVA CCL和随后的PRK治疗一年后,显着的临床改善和明显的稳定性似乎证实了这种治疗KC的方法。可以在消融交联的角膜组织时考虑调整后的诺模图,以避免过度矫正。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号